Tamar Peretz

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Doron Lipson, Marzia Capelletti, Roman Yelensky et al. · Nature Medicine · 2012 · 860 citations · Full text

Tumor Biology, Radiation Oncology, Lung Cancer Biopsies +13

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

Jeffery P. Struewing, Dvorah Abeliovich, Tamar Peretz et al. · Nature Genetics · 1995 · 657 citations

Carrier Frequency, Allelic Variant, Ashkenazi Jewish Individuals +9

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

Dvorah Abeliovich, Luna Kaduri, Israela Lerer et al. · PubMed · 1997 · 359 citations

Determinants of the Use of Complementary Therapies by Patients With Cancer

Ora Paltiel, Malka Avitzour, Tamar Peretz et al. · Journal of Clinical Oncology · 2001 · 243 citations

Heparanase Gene Silencing, Tumor Invasiveness, Angiogenesis, and Metastasis

Evgeny Edovitsky, Michael Elkin, Eyal Zcharia et al. · JNCI Journal of the National Cancer Institute · 2004 · 237 citations · Full text